alexa Leader 8: Type 2 Diabetes Patients: A Comparison of Baseline Characteristics of Eastern and Western European Participants with Established Cardiovascular Disease in the LEADER Trial
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Leader 8: Type 2 Diabetes Patients: A Comparison of Baseline Characteristics of Eastern and Western European Participants with Established Cardiovascular Disease in the LEADER Trial

Franek E1,2*, Rutten GEHM3, Orsted DD4, Baeres FMM4, Mota M5, Jacob S6, Bain SC7, Vidal J8 and Haluzik M9

1Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland

2Department of Internal Diseases, Endocrinology and Diabetology, Central Clinical Hospital MSW, Warsaw, Poland

3Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands

4Novo Nordisk, Denmark

5University of Medicine and Pharmacy of Craiova, Romania

6Kardio Metabolischen Instituts, Villingen--Schwenninge, Germany

7Institute of Life Science, Swansea, University Medical School, UK

8Universitat de Barcelona, Hospital Clinic Universitari, Barcelona, Spain

9Institute of Endocrinology and Institute of Medical Biochemistry and Laboratory Diagnostics of 1st Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic

*Corresponding Author:
Dr. Edward Franek
Department of Internal Diseases
Endocrinology and Diabetology Central Clinical Hospital MSW
ul. Woloska 137, 02-507 Warsaw, Poland
Tel: +48225081405
E-mail: [email protected]

Received date: January 11, 2016; Accepted date: February 10, 2016; Published date: February 15, 2016

Citation: Franek E, Rutten GEHM, Orsted DD, Baeres FMM, Mota M, et al. (2016) Leader 8: Type 2 Diabetes Patients: A Comparison of Baseline Characteristics of Eastern and Western European Participants with Established Cardiovascular Disease in the LEADER Trial. J Diabetes Metab 7:646. doi: 10.4172/2155-6156.1000646

Copyright: © 2016 Franek E, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Aim: The aim of the present analysis was to compare cardiovascular disease risk factors in patients from
different countries in Europe, using baseline data from the Liraglutide Effect and Action in Diabetes: Evaluation of
cardiovascular outcome Results (LEADER) trial.
Methods: Baseline characteristics and treatments were compared between the subgroup of patients with
established cardiovascular disease included in this study from the Eastern European Union (EEU), Western
European Union (WEU), and Russia and Serbia (Ru/Se).
Results: Glycaemic control was similar in the EEU and WEU, and poorest in Ru/Se, although WEU patients
were older and had longer diabetes duration. Systolic blood pressure was lowest in Ru/Se, whereas diastolic blood
pressure was lowest in the WEU. Control of dyslipidaemia was best in the WEU, and worst in Ru/Se. The percentage
of patients meeting all three targets for cardiovascular risk factors (HbA1c: ≤ 64 mmol/mol [8.0%], blood pressure:
<140/<90 mmHg and low-density lipoprotein [LDL]-cholesterol: 1.8 mmol/L [70 mg/dL]) was 9.7%, 6.4% and 3.2%
in the WEU, EEU and Ru/Se, respectively. Metformin and sulphonylurea treatment was more frequent in the EEU
than WEU and Ru/Se. Insulin, in turn, was used less frequently in the EEU than WEU and Ru/Se. The use of newer
drugs was small and differences could not be subjected to statistical analyses. Statins were used most frequently in
WEU countries and least frequently in Ru/Se.
Conclusion: The high cardiovascular risk patients in the WEU were older and had longer diabetes duration,
when compared with EEU and Ru/Se. Despite this, they had a lower body mass index (BMI), similar blood pressure
and better lipid control. Although the differences were small, the percentage of patients meeting all three treatment
targets was low across all regions studied.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords